Coverage · Recent News · Press Resources
Recent coverage, announcements, and the resources journalists need to write about the work.
New publication on FDA regulatory strategy, frontier therapeutics, and capital decisions in healthcare. Read at thehillmanletter.substack.com.
The private family office founded in Dallas in 1995 continues its focus on inflammation, damaged tissue, and tumor-based cancer platforms grounded in FDA biologics pathway thinking.
Targeted Osmotic Lysis explainer, mechanism walkthrough, and trial information goes live for clinicians and the curious. See fixcancer.org.
The Andrew Hillman Scholarship for Entrepreneurs at SMU's Cox School of Business endowed for undergraduate students pursuing entrepreneurial work.
Research grant endowed for graduate work at the intersection of biotechnology and regulatory science.
Verified bio at three lengths, fact sheet, speaking topics, headshots, downloads. Open the press kit.
The primary-source operating record and timeline at andrewhillmanrecord.com. Verified directly, no PR filter.
For interviews, press, podcasts, and quote requests: ajhillman@gmail.com. Direct response.
FDA biologics pathway, exosome regulatory science, family office structure, compliance, expert witness, Dallas biotech ecosystem.